• Teva Pharmaceutical Industries average return on tangible equity for 2023 was 11.43, a 35.75% decline from 2022.
• Teva Pharmaceutical Industries average return on tangible equity for 2022 was 8.42, a 7.17% increase from 2021.
• Teva Pharmaceutical Industries average return on tangible equity for 2021 was 9.07, a 18.87% decline from 2020.

Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.